The next step in chronic kidney disease staging: individualized risk prediction

Affiliations

¹ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; John Walls Renal Unit, University Hospitals of Leicester, Leicester, UK. Electronic address: rwlm2@le.ac.uk.
² Department of Renal Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK; Institute of Immunity and Ageing, University of Birmingham, Birmingham, UK.
³ Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK; United Kingdom Renal Registry, Bristol, UK; Royal Free NHS Foundation Trust, London, UK.
⁴ Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Editorial

Rupert W Major et al. Kidney Int. 2022 Sep.

. 2022 Sep;102(3):456-459.

doi: 10.1016/j.kint.2022.06.012. Epub 2022 Jul 13.

¹ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; John Walls Renal Unit, University Hospitals of Leicester, Leicester, UK. Electronic address: rwlm2@le.ac.uk.
² Department of Renal Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK; Institute of Immunity and Ageing, University of Birmingham, Birmingham, UK.
³ Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK; United Kingdom Renal Registry, Bristol, UK; Royal Free NHS Foundation Trust, London, UK.
⁴ Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

No abstract available

Keywords: albuminuria; chronic kidney disease; proteinuria.

Publication types